Your browser doesn't support javascript.
loading
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.
Ho, Gwo Yaw; Vandenberg, Cassandra J; Lim, Ratana; Christie, Elizabeth L; Garsed, Dale W; Lieschke, Elizabeth; Nesic, Ksenija; Kondrashova, Olga; Ratnayake, Gayanie; Radke, Marc; Penington, Jocelyn S; Carmagnac, Amandine; Heong, Valerie; Kyran, Elizabeth L; Zhang, Fan; Traficante, Nadia; Huang, Ruby; Dobrovic, Alexander; Swisher, Elizabeth M; McNally, Orla; Kee, Damien; Wakefield, Matthew J; Papenfuss, Anthony T; Bowtell, David D L; Barker, Holly E; Scott, Clare L.
Affiliation
  • Ho GY; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Vandenberg CJ; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
  • Lim R; The Royal Women's Hospital, Parkville, VIC, Australia.
  • Christie EL; School of Clinical Sciences, Monash University, Clayton Road, Clayton, VIC 3168, Australia.
  • Garsed DW; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Lieschke E; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
  • Nesic K; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Kondrashova O; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Ratnayake G; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
  • Radke M; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Penington JS; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
  • Carmagnac A; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Heong V; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
  • Kyran EL; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Zhang F; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
  • Traficante N; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Huang R; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
  • Dobrovic A; The Royal Women's Hospital, Parkville, VIC, Australia.
  • Swisher EM; University of Washington, Seattle, WA, USA.
  • McNally O; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Kee D; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Wakefield MJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Papenfuss AT; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Bowtell DDL; Department of Surgery, Austin Health, University of Melbourne, Heidelberg, VIC, Australia.
  • Barker HE; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Scott CL; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
Ther Adv Med Oncol ; 15: 17588359231208674, 2023.
Article de En | MEDLINE | ID: mdl-38028140
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Ther Adv Med Oncol Année: 2023 Type de document: Article Pays d'affiliation: Australie Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Ther Adv Med Oncol Année: 2023 Type de document: Article Pays d'affiliation: Australie Pays de publication: Royaume-Uni